[Treatment of rheumatic diseases of soft tissues with Mobilisin Gel. Results of a double-blind study].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000698:Analgesia; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005439:Flufenamic Acid / Q000627:therapeutic use*; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D009220:Myositis / Q000188:drug therapy*; D009824:Ointments; D012459:Salicylates / Q000627:therapeutic use*; D052256:Tendinopathy / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D006025:Glycosaminoglycans; C039246:Mobilisin; D009824:Ointments; D012459:Salicylates; D005439:Flufenamic Acid
Die Behandlung von weichteilrheumatischen Erkrankungen mit Mobilisin Gel. Resultate einer Doppelblind-Studie.